FDA inspection

Homayoon (nmi) Khanlou, M.D.: FDA inspection ending Jun 6, 2008

FDA inspection 522432 · Voluntary Action Indicated (VAI) · Beverly Hills, CA

Key facts

Inspection ID 522432
Firm Homayoon (nmi) Khanlou, M.D.
FEI number 3006760992
Address 99 N La Cienega Blvd Ste 200
City Beverly Hills
State CA
ZIP 90211-2285
Fiscal year 2008
Inspection end date Jun 6, 2008
Classification Voluntary Action Indicated (VAI)
Project area Bio-Research Monit: Human Drugs
Product type Drugs

At a glance

  • 1–9 Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections